UNGAP best practice for improving solubility data quality of orally administered drugs

M. Vertzoni, J. Alsenz, P. Augustijns, A. Bauer-Brandl, C. A.S. Bergström, J. Brouwers, A. Müllerz, G. Perlovich, C. Saal, K. Sugano, C. Reppas*

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

11 Citationer (Scopus)
34 Downloads (Pure)

Abstract

An important goal of the European Cooperation in Science and Technology (COST) Action UNGAP (UNderstanding Gastrointestinal Absorption-related Processes, www.ungap.eu) is to improve standardization of methods relating to the study of oral drug absorption. Solubility is a general term that refers to the maximum achievable concentration of a compound dissolved in a liquid medium. For orally administered drugs, relevant information on drug properties is crucial during drug (product) development and at the regulatory level. Collection of reliable and reproducible solubility data requires careful application and understanding of the limitations of the selected experimental method. In addition, the purity of a compound and its solid state form, as well as experimental parameters such as temperature of experimentation, media related factors, and sample handling procedures can affect data quality. In this paper, an international consensus developed by the COST UNGAP network on recommendations for collecting high quality solubility data for the development of orally administered drugs is proposed.

OriginalsprogEngelsk
Artikelnummer106043
TidsskriftEuropean Journal of Pharmaceutical Sciences
Vol/bind168
Antal sider21
ISSN0928-0987
DOI
StatusUdgivet - 1 jan. 2022

Bibliografisk note

Publisher Copyright:
© 2021

Citationsformater